AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE

RecruitingNAAges 18 Years - anyAllShanghai Chest Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study aims to compare the efficacy and safety of endobronchial ultrasound-guided transtunnel forceps biopsy to transbronchial needle aspiration in diagnosing inadequate lymph node specimens based on macroscopic on-site evaluation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age โ‰ฅ 18 years; 2. Chest imaging shows mediastinal or hilar lymphadenopathy (short axis โ‰ฅ10 mm), requiring EBUS-TBNA for definitive diagnosis; 3. EBUS-TBNA can be performed on these lymph nodes, and the specimens obtained from conventional EBUS-TBNA with three needle passes are inadequate (macroscopic visible core \< 30 mm); 4. Willing to participate in this clinical study and sign the informed consent form. Exclusion Criteria: 1. Enlarged lymph nodes are identified as cystic or abscesses; 2. Severe coagulopathy, insufficient anticoagulants/antiplatelets withdraw time or bleeding diathesis (platelets\<50\*109/L, INR\>1.3) that do not meet bronchoscopy requirements; 3. Other contraindications to bronchoscopy or transbronchial biopsy, such as severe cardiopulmonary insufficiency, intolerance to anesthesia, or endoscopic procedures; 4. Patients who have participated in another clinical trial within the past three months; 5. Vulnerable groups, such as pregnant women 6. Any other condition that the investigator considers inappropriate for participation in this study.
๐Ÿ’Š

What it tests

  • EBUS-TBNA
  • EBUS-TTFB
๐Ÿ“

Where

3 sites
The Fourth Affiliated Hospital of China Medical University
Shenyang, China
Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Huzhou Central Hospital
Huizhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy